Theralase Technologies Inc. (TLTFF)
USD 0.14
(-1.2%)
USD 0.14
(-1.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 562.13 Thousand CAD | -51.42% |
| 2022 | 628.17 Thousand CAD | 102.67% |
| 2021 | 309.94 Thousand CAD | 14.93% |
| 2020 | 269.68 Thousand CAD | 343.88% |
| 2019 | 60.75 Thousand CAD | -93.59% |
| 2018 | 947.63 Thousand CAD | -32.19% |
| 2017 | 1.39 Million CAD | 24.52% |
| 2016 | 1.12 Million CAD | -14.69% |
| 2015 | 1.31 Million CAD | 42.81% |
| 2014 | 921.28 Thousand CAD | 15.29% |
| 2013 | 799.08 Thousand CAD | -36.03% |
| 2012 | 1.24 Million CAD | -9.97% |
| 2011 | 1.38 Million CAD | 1.09% |
| 2010 | 1.37 Million CAD | -12.03% |
| 2009 | 1.56 Million CAD | 5.45% |
| 2008 | 1.47 Million CAD | 27.17% |
| 2007 | 1.16 Million CAD | 8.86% |
| 2006 | 1.06 Million CAD | 17.48% |
| 2005 | 909.62 Thousand CAD | 89.35% |
| 2004 | 480.39 Thousand CAD | 3864.95% |
| 2003 | 12.11 Thousand CAD | 410.15% |
| 2002 | 2375.00 CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 344.00 CAD | -99.78% |
| 2024 Q2 | -33.13 Thousand CAD | 8028.78% |
| 2023 Q4 | 154.75 Thousand CAD | 9.24% |
| 2023 Q1 | 92.52 Thousand CAD | -54.74% |
| 2023 FY | 305.15 Thousand CAD | -51.42% |
| 2023 Q2 | 44.29 Thousand CAD | -52.12% |
| 2023 Q3 | 141.67 Thousand CAD | 219.83% |
| 2022 Q4 | 204.4 Thousand CAD | 42.96% |
| 2022 Q2 | 189.55 Thousand CAD | 107.77% |
| 2022 Q3 | 142.98 Thousand CAD | -24.57% |
| 2022 Q1 | 91.23 Thousand CAD | 50.73% |
| 2022 FY | 628.17 Thousand CAD | 102.67% |
| 2021 Q2 | 149.3 Thousand CAD | 196.72% |
| 2021 FY | 309.94 Thousand CAD | 14.93% |
| 2021 Q4 | 60.52 Thousand CAD | 21.58% |
| 2021 Q3 | 49.78 Thousand CAD | -66.66% |
| 2021 Q1 | 50.32 Thousand CAD | -60.13% |
| 2020 FY | 269.68 Thousand CAD | 343.88% |
| 2020 Q3 | 80.12 Thousand CAD | 56.31% |
| 2020 Q2 | 51.26 Thousand CAD | 323.79% |
| 2020 Q1 | 12.09 Thousand CAD | 115.1% |
| 2020 Q4 | 126.19 Thousand CAD | 57.5% |
| 2019 Q1 | 36.92 Thousand CAD | -83.97% |
| 2019 Q2 | 65.86 Thousand CAD | 78.36% |
| 2019 Q3 | 38.05 Thousand CAD | -42.22% |
| 2019 Q4 | -80.09 Thousand CAD | -310.45% |
| 2019 FY | 60.75 Thousand CAD | -93.59% |
| 2018 Q2 | 280.03 Thousand CAD | 41.19% |
| 2018 FY | 947.63 Thousand CAD | -32.19% |
| 2018 Q4 | 230.3 Thousand CAD | -3.62% |
| 2018 Q1 | 198.33 Thousand CAD | -67.02% |
| 2018 Q3 | 238.96 Thousand CAD | -14.67% |
| 2017 Q4 | 601.46 Thousand CAD | 246.93% |
| 2017 Q3 | 173.36 Thousand CAD | -46.24% |
| 2017 FY | 1.39 Million CAD | 24.52% |
| 2017 Q1 | 300.19 Thousand CAD | -9.14% |
| 2017 Q2 | 322.47 Thousand CAD | 7.42% |
| 2016 Q2 | 332.16 Thousand CAD | 18.76% |
| 2016 Q4 | 330.39 Thousand CAD | 63.83% |
| 2016 Q3 | 201.67 Thousand CAD | -39.29% |
| 2016 FY | 1.12 Million CAD | -14.69% |
| 2016 Q1 | 279.68 Thousand CAD | -54.28% |
| 2015 Q2 | 201.27 Thousand CAD | -13.67% |
| 2015 FY | 1.31 Million CAD | 42.81% |
| 2015 Q1 | 233.14 Thousand CAD | -2.15% |
| 2015 Q4 | 611.78 Thousand CAD | 127.06% |
| 2015 Q3 | 269.43 Thousand CAD | 33.86% |
| 2014 Q3 | 68.4 Thousand CAD | -81.76% |
| 2014 Q2 | 374.97 Thousand CAD | 56.48% |
| 2014 Q1 | 239.63 Thousand CAD | 505.57% |
| 2014 FY | 921.28 Thousand CAD | 15.29% |
| 2014 Q4 | 238.26 Thousand CAD | 248.29% |
| 2013 FY | 799.08 Thousand CAD | -36.03% |
| 2013 Q4 | -59.08 Thousand CAD | -125.74% |
| 2013 Q3 | 229.51 Thousand CAD | -41.56% |
| 2013 Q2 | 392.72 Thousand CAD | 66.46% |
| 2013 Q1 | 235.92 Thousand CAD | 40.78% |
| 2012 Q4 | 167.58 Thousand CAD | -39.84% |
| 2012 Q1 | 299.84 Thousand CAD | -14.44% |
| 2012 Q2 | 503.17 Thousand CAD | 67.81% |
| 2012 FY | 1.24 Million CAD | -9.97% |
| 2012 Q3 | 278.55 Thousand CAD | -44.64% |
| 2011 Q4 | 350.44 Thousand CAD | 16.76% |
| 2011 Q1 | 272.76 Thousand CAD | -22.85% |
| 2011 Q2 | 464.1 Thousand CAD | 70.15% |
| 2011 Q3 | 300.13 Thousand CAD | -35.33% |
| 2011 FY | 1.38 Million CAD | 1.09% |
| 2010 Q2 | 433.51 Thousand CAD | 49.45% |
| 2010 Q4 | 353.53 Thousand CAD | 19.69% |
| 2010 FY | 1.37 Million CAD | -12.03% |
| 2010 Q1 | 290.06 Thousand CAD | -44.1% |
| 2010 Q3 | 295.38 Thousand CAD | -31.86% |
| 2009 Q4 | 518.91 Thousand CAD | 61.63% |
| 2009 Q1 | 290.02 Thousand CAD | -46.83% |
| 2009 Q2 | 430.12 Thousand CAD | 48.3% |
| 2009 Q3 | 321.05 Thousand CAD | -25.36% |
| 2009 FY | 1.56 Million CAD | 5.45% |
| 2008 Q4 | 545.51 Thousand CAD | 66.44% |
| 2008 Q1 | 219.12 Thousand CAD | -15.61% |
| 2008 Q2 | 387.07 Thousand CAD | 76.65% |
| 2008 Q3 | 327.75 Thousand CAD | -15.33% |
| 2008 FY | 1.47 Million CAD | 27.17% |
| 2007 Q2 | 326.28 Thousand CAD | 3.03% |
| 2007 FY | 1.16 Million CAD | 8.86% |
| 2007 Q3 | 260.73 Thousand CAD | -20.09% |
| 2007 Q4 | 259.64 Thousand CAD | -0.42% |
| 2007 Q1 | 316.68 Thousand CAD | 50.41% |
| 2006 Q2 | 324.18 Thousand CAD | 22.14% |
| 2006 FY | 1.06 Million CAD | 17.48% |
| 2006 Q3 | 268.49 Thousand CAD | -17.18% |
| 2006 Q4 | 210.54 Thousand CAD | -21.58% |
| 2006 Q1 | 265.41 Thousand CAD | -16.06% |
| 2005 Q2 | 226.98 Thousand CAD | 58.4% |
| 2005 FY | 909.62 Thousand CAD | 89.35% |
| 2005 Q4 | 316.19 Thousand CAD | 41.69% |
| 2005 Q1 | 143.29 Thousand CAD | -49.83% |
| 2005 Q3 | 223.16 Thousand CAD | -1.68% |
| 2004 FY | 480.39 Thousand CAD | 3864.95% |
| 2004 Q3 | 83.15 Thousand CAD | 95.47% |
| 2004 Q4 | 285.61 Thousand CAD | 243.48% |
| 2004 Q2 | 42.53 Thousand CAD | -38.01% |
| 2004 Q1 | 68.62 Thousand CAD | 162.99% |
| 2003 Q2 | 597.00 CAD | 10.97% |
| 2003 Q1 | 538.00 CAD | -3.06% |
| 2003 Q3 | 494.00 CAD | -17.25% |
| 2003 FY | 12.11 Thousand CAD | 410.15% |
| 2003 Q4 | 26.09 Thousand CAD | 5181.98% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 Q4 | 555.00 CAD | -19.8% |
| 2002 Q3 | 692.00 CAD | 0.0% |
| 2002 FY | 2375.00 CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Polarean Imaging plc | 335.48 Thousand USD | -67.56% |
| Medical Supply International USA, Inc. | 1.75 Million USD | 68.037% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | -20.529% |
| IR-Med Inc. | -17 Thousand USD | 3406.671% |
| Avitar, Inc. | 836.7 Thousand USD | 32.816% |
| AVITA Medical, Inc. | 41.68 Million USD | 98.652% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 56313.4% |
| Össur hf. | 485.57 Million USD | 99.884% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 387.8% |
| QHSLab, Inc. | 793.6 Thousand USD | 29.167% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | 99.884% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 96.643% |
| Escalon Medical Corp. | 5.14 Million USD | 89.077% |
| Aurora Spine Corporation | 8.21 Million USD | 93.154% |
| BrainsWay Ltd. | 23.09 Million USD | 97.566% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 105.1 Thousand USD | -434.841% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 98.398% |
| Vivos Inc. | -6036.00 USD | 9413.022% |
| MicroPort Scientific Corporation | 532.09 Million USD | 99.894% |
| Kelyniam Global, Inc. | 2.03 Million USD | 72.391% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 174.284% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -893.275% |
| Nanomix Corporation | -69.45 Thousand USD | 909.315% |
| Theraclion SA | -1.08 Million USD | 152.031% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | 4.326% |
| Positron Corporation | -353.46 Thousand USD | 259.035% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | 46.233% |
| Lombard Medical, Inc. | 955 Thousand USD | 41.138% |
| ALR Technologies Inc. | 4945.00 USD | -11267.725% |
| Stratec SE | 71.58 Million USD | 99.215% |
| Vycor Medical, Inc. | 1.31 Million USD | 57.273% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 4457.628% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -172.327% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 96.086% |
| VMS Rehab Systems, Inc. | -10.44 USD | 5384525.287% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -1461.483% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -109.3% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | -8000.00 USD | 7126.675% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | 48.619% |
| Urologix, Inc. | 6.09 Million USD | 90.774% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 277.502% |
| SS Innovations International, Inc. | 713.44 Thousand USD | 21.209% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 99.986% |
| NIOX Group Plc | 28.13 Million USD | 98.002% |
| Fuse Medical, Inc. | 10.73 Million USD | 94.763% |
| Broncus Holding Corporation | 7.22 Million USD | 92.222% |
| Brain Scientific Inc. | 54.32 Thousand USD | -934.761% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | 29.695% |
| Health Logic Interactive Inc. | - USD | -Infinity% |